Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

Healthcare Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

CSE:BIOV - Post Discussion

BioVaxys Technology Corp. > BIOV LONGS~DAY TRADERS MIGHT TAKE PROFITS EOW~MONDAY
View:
Post by moneywagon on Dec 29, 2023 1:31pm

BIOV LONGS~DAY TRADERS MIGHT TAKE PROFITS EOW~MONDAY

IS THE FOCUS here people....Fridays are a tough one if Brokers don't want to window dress over the weekend.(hold shares) . It's gonna be a wild 2024!!!
Comment by Mario79 on Dec 29, 2023 1:43pm
I won't be surprised if the sp will be in the 20's by end of January. Jmho. Any guesses? 
Comment by newinvestoor on Dec 29, 2023 1:48pm
The amount of volume the last couple of weeks seem to indicate something is up.  This seems to be the driving news. @Tobias323 KEY POINTS! As part of the Company’s renewed strategic focus on immunotherapeutics, BioVaxys recently announced that it executed a non-binding Letter of Intent ("LOI") to acquire a core platform technology and entire immunotherapeutics intellectual ...more  
BioVaxys Technology Corp.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities